Active Pre-seed Biotech Investors (2026)

Raising capital in the Biotech space requires finding partners who understand your specific market dynamics. The investors listed here are actively deploying capital and looking for high-growth opportunities with defensible competitive advantages. Pre-seed investors primarily back the founders' vision, early prototypes, and initial market validation before substantial revenue exists.

Sector: Biotech Stage: Pre-Seed + Geography + Check size

Lisheng Wang

Biotech · $250K-$3M

TSVC is a seed-stage venture capital firm founded in 2010 that identifies forward-thinking entrepreneurs

Active now

MM

Mark Martin

Biotech · $60K–$500K

Cybernetix Ventures invests in pre-seed, seed, and Series A robotics, automation, and industrial AI startups across manufacturing, logistics...

Active now

FT

Finian Tan

Biotech

Vickers Venture Partners, founded by Dr. Finian Tan in 2005, invests in early-stage deep-tech companies and life sciences ventures globally...

Active now

Jason McBride

Biotech · $750K–$3,000K

AIX Ventures, where Jason McBride is a Partner, invests exclusively in AI-native companies where artificial intelligence serves as the core...

Active now

Jennifer Neundorfer

Biotech

January Ventures invests in outlier founders transforming traditional industries and processes through B2B software at the pre-seed stage, b...

Active now

RC

Rowan Chapman

Biotech · $500K-$3M

BEVC partners with entrepreneurs on their unique journeys to create, scale, and exit meaningful biotech and tech ventures. The fund invests...

Active now

BD

Brian Dixon

Biotech · $100K–$250K

Brian Dixon is committed to empowering underrepresented entrepreneurs by providing access to both capital and strategic advice to help their...

Active now

Tom Williams

Biotech · Up to $250K pre-investment threshold

Tom Williams founded Heron Rock Capital as an exclusively first-check investor platform backing exceptional founders and difficult ideas bef...

Active now

Related

Get matched free